{"id":"https://openalex.org/W7220837349","doi":"https://doi.org/10.3389/fpsyt.2026.1933443","title":"Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment: study protocol for a randomized controlled trial","display_name":"Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment: study protocol for a randomized controlled trial","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220837349","doi":"https://doi.org/10.3389/fpsyt.2026.1933443","pmid":"https://pubmed.ncbi.nlm.nih.gov/42909039","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13683708"},"language":"en","primary_location":{"id":"doi:10.3389/fpsyt.2026.1933443","doi":"https://doi.org/10.3389/fpsyt.2026.1933443","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpsyt.2026.1933443","pdf_url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1933443/pdf","source":{"id":"https://openalex.org/S92766711","display_name":"Frontiers in Psychiatry","issn_l":"1664-0640","issn":["1664-0640"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1933443/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029198441","display_name":"Saeede Jafari","orcid":"https://orcid.org/0000-0002-5357-9250","observed_orcids":["https://orcid.org/0000-0002-5357-9250"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Saeede Jafari","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017050426","display_name":"Afarin Rahimi\u2010Movaghar","orcid":"https://orcid.org/0000-0002-5761-1668","observed_orcids":["https://orcid.org/0000-0002-5761-1668"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Afarin Rahimi-Movaghar","raw_affiliation_strings":["Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078178851","display_name":"Alireza Noroozi","orcid":"https://orcid.org/0000-0002-5838-4348","observed_orcids":["https://orcid.org/0000-0002-5838-4348","https://orcid.org/0000-0002-2217-9289"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":true,"raw_author_name":"Alireza Noroozi","raw_affiliation_strings":["Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088712428","display_name":"Pooneh Malekifar","orcid":"https://orcid.org/0000-0003-3863-7093","observed_orcids":["https://orcid.org/0000-0003-3863-7093"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Pooneh Malekifar","raw_affiliation_strings":["Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046788655","display_name":"Akbar Fotouhi","orcid":"https://orcid.org/0000-0002-6438-6833","observed_orcids":["https://orcid.org/0000-0002-6438-6833"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Akbar Fotouhi","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences","institution_ids":["https://openalex.org/I70640408"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078178851"],"corresponding_institution_ids":["https://openalex.org/I70640408"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.76565477,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1933443","last_page":"1933443"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.921999990940094},{"id":"https://openalex.org/keywords/sublingual-buprenorphine","display_name":"sublingual buprenorphine","score":0.9869999885559082},{"id":"https://openalex.org/keywords/opioid-withdrawal-management","display_name":"opioid withdrawal management","score":0.8069999814033508},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.34599998593330383},{"id":"https://openalex.org/keywords/clonidine","display_name":"clonidine","score":0.8429999947547913},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.8939999938011169},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/trazodone","display_name":"trazodone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/opioid-craving","display_name":"opioid craving","score":0.7950000166893005},{"id":"https://openalex.org/keywords/withdrawal-symptoms","display_name":"withdrawal symptoms","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9139999747276306},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.892300009727478},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.7211999893188477},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6886000037193298},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6326000094413757},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.5631999969482422},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.5600000023841858},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.5274999737739563},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4675000011920929},{"id":"https://openalex.org/C2778903061","wikidata":"https://www.wikidata.org/wiki/Q17156814","display_name":"Methadone maintenance","level":3,"score":0.41449999809265137},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3750999867916107},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.3693999946117401},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.3359000086784363},{"id":"https://openalex.org/C202953159","wikidata":"https://www.wikidata.org/wiki/Q382695","display_name":"Intention-to-treat analysis","level":3,"score":0.2784000039100647},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.273499995470047},{"id":"https://openalex.org/C2778062832","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Drug withdrawal","level":3,"score":0.2671999931335449}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fpsyt.2026.1933443","doi":"https://doi.org/10.3389/fpsyt.2026.1933443","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpsyt.2026.1933443","pdf_url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1933443/pdf","source":{"id":"https://openalex.org/S92766711","display_name":"Frontiers in Psychiatry","issn_l":"1664-0640","issn":["1664-0640"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Psychiatry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13683708","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683708/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683708/pdf/fpsyt-17-1933443.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Psychiatry","raw_type":"Text"},{"id":"pmid:42909039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42909039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in psychiatry","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f4c19af965564496bf9d3b3ef905d7e8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/f4c19af965564496bf9d3b3ef905d7e8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Psychiatry, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fpsyt.2026.1933443","doi":"https://doi.org/10.3389/fpsyt.2026.1933443","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpsyt.2026.1933443","pdf_url":"https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1933443/pdf","source":{"id":"https://openalex.org/S92766711","display_name":"Frontiers in Psychiatry","issn_l":"1664-0640","issn":["1664-0640"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322670","display_name":"Tehran University of Medical Sciences and Health Services","ror":"https://ror.org/01c4pz451"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220837349.pdf","grobid_xml":"https://content.openalex.org/works/W7220837349.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1577400252","https://openalex.org/W1984398689","https://openalex.org/W2004685297","https://openalex.org/W2018914766","https://openalex.org/W2031219308","https://openalex.org/W2097910464","https://openalex.org/W2110777573","https://openalex.org/W2120263268","https://openalex.org/W2121821947","https://openalex.org/W2140341041","https://openalex.org/W2164678034","https://openalex.org/W2429180991","https://openalex.org/W2570948865","https://openalex.org/W2768214444","https://openalex.org/W2796165444","https://openalex.org/W2796812403","https://openalex.org/W2958293187","https://openalex.org/W3014710327","https://openalex.org/W3036889326","https://openalex.org/W3120480860","https://openalex.org/W4410869734","https://openalex.org/W4411326897","https://openalex.org/W4412685896"],"related_works":["https://openalex.org/W4396733545","https://openalex.org/W4238238277","https://openalex.org/W2796812403","https://openalex.org/W2768214444","https://openalex.org/W2570948865","https://openalex.org/W3014710327","https://openalex.org/W7204255083","https://openalex.org/W1988132987","https://openalex.org/W4324387607","https://openalex.org/W3118218653"],"abstract_inverted_index":{"Background:":[0],"Extended-release":[1],"injectable":[2],"naltrexone":[3,166],"(XR-NTX),":[4],"a":[5,34,103,220,247],"long-acting":[6],"opioid":[7,19,30,275],"antagonist,":[8],"is":[9,41],"an":[10],"effective":[11],"relapse":[12],"prevention":[13],"strategy":[14],"in":[15,87,227,308],"the":[16,74,240,253,261,264,287],"treatment":[17,57,127,307],"of":[18,29,78,137,147,153,158,163,182,188,242,263,272,293,305,322],"use":[20],"disorder":[21],"(OUD).":[22],"However,":[23],"standard":[24],"XR-NTX":[25,56,65,89,259,306],"initiation":[26,66,90,304],"requires":[27],"completion":[28],"withdrawal":[31,85,142,177,265,273],"management":[32,86,266],"and":[33,48,50,76,121,160,171,213,219,234,256,278,312],"1-2":[35],"week":[36],"opioid-free":[37],"period.":[38,223,267],"This":[39,69,96],"interval":[40],"associated":[42],"with":[43,93,111,128,310],"heightened":[44],"vulnerability":[45],"to":[46,54,72,113,135,192,286,301],"lapse":[47],"relapse,":[49],"many":[51],"patients":[52,92,107,309],"fail":[53],"initiate":[55],"successfully.":[58],"Therefore,":[59],"alternative":[60],"strategies":[61],"that":[62],"enable":[63],"rapid":[64,303],"are":[67,117,122,132,239,283],"needed.":[68],"study":[70],"aimed":[71],"compare":[73],"effectiveness":[75],"safety":[77],"naltrexone-accelerated":[79],"(NA)":[80],"versus":[81],"sublingual":[82],"buprenorphine":[83,131,154,189],"(SB)":[84],"facilitating":[88],"among":[91],"OUD.":[94],"Methods:":[95],"single-center,":[97],"open-label,":[98],"randomized":[99],"controlled":[100],"trial":[101,295,317],"uses":[102],"parallel-group":[104],"design.":[105],"Eligible":[106],"aged":[108],"18-60":[109],"years":[110],"moderate":[112],"severe":[114],"OUD":[115,311],"who":[116,244],"actively":[118],"using":[119],"opioids":[120,255],"not":[123],"receiving":[124],"regular":[125],"maintenance":[126],"methadone":[129],"or":[130,174],"randomly":[133],"assigned":[134],"one":[136,145,151,156,180],"two":[138],"groups:":[139],"(1)":[140,245],"NA":[141],"management,":[143,178],"comprising":[144,179],"day":[146,152,157,181],"adjunctive":[148,183],"non-opioid":[149,184,225],"medications,":[150,185],"administration,":[155],"washout,":[159],"four":[161],"days":[162,187],"gradual":[164],"oral":[165],"titration":[167],"(1,":[168],"3,":[169,202],"12,":[170],"25":[172],"mg/day);":[173],"(2)":[175,257],"SB":[176],"six":[186],"tapering":[190],"(up":[191],"8":[193],"mg":[194,199,204,209,215],"on":[195,200,205,210,216],"Day":[196,201,211,217],"2,":[197],"6":[198],"4":[203],"Days":[206],"4-5,":[207],"2":[208],"6,":[212],"1":[214],"7),":[218],"seven-day":[221],"washout":[222],"Adjunctive":[224],"medications":[226],"both":[228],"groups":[229],"comprised":[230],"clonidine,":[231],"clonazepam,":[232],"gabapentin,":[233],"trazodone.":[235],"The":[236,291],"primary":[237],"outcomes":[238,269],"proportions":[241],"participants":[243],"achieve":[246],"negative":[248],"urine":[249],"drug":[250],"test":[251],"for":[252],"assessed":[254],"receive":[258],"at":[260],"end":[262],"Secondary":[268],"include":[270],"severity":[271],"symptoms,":[274],"craving":[276],"intensity,":[277],"adverse":[279],"effects.":[280],"All":[281],"analyses":[282],"conducted":[284],"according":[285],"intention-to-treat":[288],"principle.":[289],"Discussion:":[290],"findings":[292],"this":[294],"may":[296],"provide":[297],"clinically":[298],"relevant":[299],"evidence":[300],"support":[302],"inform":[313],"clinical":[314],"practice.":[315],"Clinical":[316,323],"registration:":[318],"https://en.irct.ir/trial/81525,":[319],"Iranian":[320],"Registry":[321],"Trials":[324],"IRCT20250123064499N1.":[325]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-08T00:00:00"}